Response by Abrahami et al to letter regarding article 'Proton pump inhibitors and risk of colorectal cancer'

Gut. 2022 Aug;71(8):1690-1691. doi: 10.1136/gutjnl-2021-326544. Epub 2021 Dec 2.

Devin Abrahami^{1

2

3}, Laurent Azoulay^{4

2

5}

¹ Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Montreal, Quebec, Canada.
² Epidemiology, Biostatistics, and Occupational Health, McGill University, Montreal, Quebec, Canada.
³ Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, Massachusetts, USA.
⁴ Centre for Clinical Epidemiology, Lady Davis Institute for Medical Research, Montreal, Quebec, Canada laurent.azoulay@mcgill.ca.
⁵ Gerald Bronfman Department of Oncology, McGill University, Montreal, Quebec, Canada.

No abstract available

Keywords: colorectal cancer; epidemiology; proton pump inhibition.

Publication types